Armata Pharmaceuticals, Inc. Recorded Big Gain

Fri, Jul 17, 2026 at 07:43 PM

Armata Pharmaceuticals, Inc. (ARMP:NYSEMKT) shot up at $4.51, representing a gain of 19.9%. The stock got featured on our News Catalysts scanner on Mon, Jul 13, 2026 at 07:34 AM in the 'AGREEMENT' category. From Mon, Jul 06, 2026, the stock recorded 22.22% Up Days and 20.00% Green Days

About Armata Pharmaceuticals, Inc. (ARMP:NYSEMKT)

Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage therapeutics. The lead product candidates are AB-SA01 for the treatment of Staphylococcus aureus infections; and AB-PA01 for the treatment of Paeruginosa infections.

Top 10 Gainers:

Sadot Group Inc. (SDOT:NASDAQ), 77.54%
Southland Holdings, Inc. (SLND:NYSEMKT), 67.33%
Callan JMB Inc. (CJMB:NASDAQ), 41.7%
Baiya International Group Inc. (BIYA:NASDAQ), 36.18%
Lulu's Fashion Lounge Holdings, Inc. (LVLU:NASDAQ), 23.16%
SemiLEDs Corporation (LEDS:NASDAQ), 22.86%
Brenmiller Energy Ltd (BNRG:NASDAQ), 21.01%
American Well Corporation (AMWL:NYSE), 20.82%
Greenland Mines Ltd (GRML:NASDAQ), 20.24%
Armata Pharmaceuticals, Inc. (ARMP:NYSEMKT), 19.95%